ROR1 expression showed a significant prognostic factor in patients with CLL, and several studies identified aberrant expression of ROR1 in other hematologic malignancies, diffuse large B cell lymphoma, follicular lymphoma, and marginal zone lymphoma [24]. The gene discussed is ROR1; the disease is hematologic disorder.